The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC

Viviane Ponath1, Miriam Frech2, Mathis Bittermann1

  • 1Institute for Tumor Immunology, Clinic for Hematology, Oncology and Immunology, Philipps University of Marburg, Hans-Meerwein-Strasse 3, 35043 Marburg, Germany.

Cancers
|October 7, 2020
PubMed

Insights

Downregulating the SKI oncogene in pancreatic cancer enhances natural killer (NK) cell killing. SKI represses NKG2D ligand expression, suggesting a combination therapy for pancreatic tumors with high SKI levels.

Area of Science:

  • Oncology
  • Immunology
  • Epigenetics

Background:

  • Histone deacetylase inhibitors (HDACi) suppress tumor growth and enhance NK cell cytotoxicity by increasing NKG2D ligand (NKG2D-L) expression.
  • CBP and p300 are key acetylases for NKG2D-L expression.
  • The role of the oncogenic transcriptional repressor SKI in this process is unknown.

Purpose of the Study:

  • To investigate the role of SKI in regulating NKG2D-L expression and NK cell-mediated cytotoxicity in pancreatic cancer.
  • To determine if SKI impacts the efficacy of HDACi in enhancing anti-tumor immunity.

Main Methods:

  • siRNA-mediated downregulation of SKI in pancreatic cancer cell lines (Panc-1, Patu8988t).
  • Assessment of NK cell-mediated cytotoxicity against SKI-depleted or control cells.
  • Analysis of NKG2D-L expression following SKI manipulation and/or HDACi treatment (LBH589, VPA).

Main Results:

  • Downregulation of SKI increased pancreatic cancer cell killing by primary NK cells.
  • This enhanced cytotoxicity did not correlate with increased NKG2D-L expression.
  • HDACi treatment induced NKG2D-L and NK cell killing independently of SKI levels.
  • Genetic ablation of SKI significantly enhanced NKG2D-L induction by HDACi.

Conclusions:

  • SKI acts as a repressor of inducible NKG2D-L expression in pancreatic cancer cells.
  • Targeting SKI in combination with HDAC inhibitors may represent a novel therapeutic strategy for pancreatic cancer, particularly in patients with high SKI expression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K